Circadian Based Time Restricted Eating for Cardiometabolic Syndrome

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Cardiometabolic Syndrome+4 MoreCircadian Based Time Restricted Eating - Behavioral
Eligibility
18 - 40
All Sexes
What conditions do you have?
Select

Study Summary

The goal of this study is to learn more about how the time in which participants consume their meals relative to their personalized circadian rhythm influences their overall cardiometabolic health and weight. The investigators are hoping to discover if a circadian-based time restricted eating intervention will improve cardiometabolic health and decrease weight. The protocol is a 46 day prospective cohort study that includes both field and in-laboratory data collection in overweight and obese individuals.

Eligible Conditions
  • Cardiometabolic Syndrome
  • Weight Loss
  • Circadian Rhythm
  • Time-Restricted Feeding
  • Cardiovascular Health

Treatment Effectiveness

Study Objectives

8 Primary · 3 Secondary · Reporting Duration: 7.5 hours

46 days
Changes in Blood Pressure
Changes in Body Fat Percentage
Changes in Body Mass Index
Changes in Glucose
Changes in Heart Rate
Changes in Hemoglobin A1c
Changes in LDL and HDL cholesterol
Changes in Total Cholesterol
Changes in Triglycerides
Changes in Weight
7.5 hours
Dim-Light Melatonin Onset

Trial Safety

Trial Design

2 Treatment Groups

Control
1 of 2
Circadian Based Time Restricted Eating
1 of 2

Active Control

Experimental Treatment

10 Total Participants · 2 Treatment Groups

Primary Treatment: Circadian Based Time Restricted Eating · No Placebo Group · N/A

Circadian Based Time Restricted Eating
Behavioral
Experimental Group · 1 Intervention: Circadian Based Time Restricted Eating · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 7.5 hours

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
893 Previous Clinical Trials
6,829,364 Total Patients Enrolled

Eligibility Criteria

Age 18 - 40 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
Oregon100.0%
What site did they apply to?
Oregon Health and Science University100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%
Why did patients apply to this trial?
  • "I gained a lot of weight during COVID and I think a big part of it was that my sleep schedule was very off due to my work situation and I was staying up until 4am or sometimes later. So I was eating late and I know everything was really off."
How many prior treatments have patients received?
0100.0%